Close to Rs 1000 crores investments announced at BioAsia
Close to 4000 acres of land already acquired for the pharmacity, Government is hopeful of completing the process of required land acquisition in the next 6 months
The 13th edition of BioAsia, kicked off yesterday at the Hyderabad International Convention Center HICC with the theme ‘Connecting the dots-Leveraging India to succeed globally’. The event witnessed participation of delegates from healthcare, biotech, pharmaceutical, life-cciences, IT, academia and start-ups. BioAsia 2016 was inaugurated by Jupally Krishna Rao, Minister of Industries, Govt of Telangana. Dignitaries present at the inauguration included, Susil Premajayantha, Minister of Science, Technology & Research, Srilanka; as the Guest of Honour, Nils Ragnar Kamsvåg, Ambassador Designate of the Kingdom of Norway and Dr Magdalena Cruz Yabar, Minister Counsellor /Deputy Head of Mission Embassy of Spain as well as Nobel Laureate Prof. Ada Yonath, Weismann Institute, Israel.
The inaugural ceremony of BioAsia 2016 witnessed many strategic partnerships and investment announcements of close to Rs 700 crores. The Telangana Government further announced 13 land approvals for biotech and pharma companies.
Unveiling the 3D walk-through of the proposed Pharmacity, Addressing on the occasion, Rao, said, “The year not only marks the 13th edition of BioAsia but has also achieved a benchmark of excellence. It is my pleasure to note that the platform has made tremendous progress in terms of international partnerships, participation from all sectors of the industry, collaboration with firms of high repute, facilitating several meaningful business interactions and being a catalyst in forming strategic agreements between Global and Indian Biotech industry. Over the next three days, BioAsia will feature interactive sessions, award ceremonies, networking dinners, Indo-Norwegian power breakfast meeting and many parallel tracks on various current industry topics. I hope the interactions will result into many more partnerships and fruitful industry collaborations this year.”
The industries minister gave away the Genome Valley Excellence Awards 2016 to Nobel Laureate Prof Ada Yonath, Weismann Institute, Israel.
Commenting on the occasion, Shakthi Nagappan, CEO, BioAsia said, “We have received an overwhelming response to the conferences, the deliberations talk sessions and the meetings. We have excellent participation from all industry stakeholders resulting into the expected attendance of delegates from more than 50+ countries for the three day event. I am also pleased to have the participation of Norway as our Principal Country partner, Spain and South Africa as Associate Country Partners. I welcome all the delegates and urge them to make the most of this knowledge sharing platform enriched with global insights and best practices.”
The inaugural ceremony saw participation from a 10 member delegation including regulatory body representatives, industry captains, high profile speakers, etc from Norway, Spain, South Africa, Srilanka, Israel and many more. Day two of BioAsia will host sessions and panel discussions on Building a strategy for India – ways to develop bio-economy, biosimilars, Make in India for Global Market, – Innovative strategies in the drug discovery and many more. Day two of the conference will also host a CEO Conclave on the theme ‘Make in India’.
Comments are closed.